Facebook
Twitter
Telegram
Report an ErrorANI Pharmaceuticals Financial Ratios 2011-2024 | ANIP
Annual Financial Ratios ANI Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
64.2 | -14.6 | -12.0 | -15.1 | 119.0 | 40.9 | -724.0 | 169.4 | 23.7 | 21.3 | 355.8 | -1.1 | -1.2 |
P/S |
2.5 | 2.2 | 2.4 | 1.6 | 3.5 | 3.1 | 4.4 | 5.2 | 4.8 | 10.9 | 3.6 | 13.7 | 147.0 |
EPS |
0.9 | -3.0 | -3.4 | -1.9 | 0.5 | 1.3 | -0.1 | 0.3 | 1.3 | 2.6 | -0.9 | -1.3 | -3.1 |
EV (Enterprise Value) |
1.43 B | 1.07 B | 822 M | 599 M | 907 M | 824 M | 985 M | 792 M | 334 M | 567 M | 99.5 M | 42.1 M | 31.3 M |
EBITDA per Share |
5.93 | 1.33 | 0.59 | 2.39 | 5.15 | 5.92 | 4.95 | 4.29 | 3.48 | 2.18 | 0.396 | -6.32 | -18.6 |
EV/EBITDA |
109.5 | 17.9 | 13.9 | 11.2 | 16.6 | 15.5 | 8.1 | 23.2 | 47.8 | -0.2 | -0.5 | ||
PEG |
0.98 | -23.38 | 0.56 | 9.0 | -1.95 | 0.03 | 5.74 | -2.28 | -0.49 | 0.06 | 4.05 | -0.02 | -0.05 |
P/B |
2.6 | 2.1 | 1.4 | 1.7 | 3.4 | 3.2 | 4.5 | 3.9 | 2.3 | 4.4 | 2.6 | 1.1 | 1.7 |
P/CF |
10.1 | -22.4 | 153.3 | 22.4 | 40.1 | 11.3 | -11.4 | -5.5 | -23.6 | -44.6 | -18.9 | -1.2 | -1.3 |
ROE % |
4.34 | -15.27 | -12.76 | -11.52 | 2.86 | 7.85 | -0.62 | 2.32 | 9.60 | 20.57 | 0.73 | -98.38 | -136.48 |
ROA % |
2.08 | -6.30 | -5.52 | -4.89 | 1.33 | 3.60 | -0.26 | 1.22 | 5.39 | 10.90 | 0.68 | -71.49 | -82.73 |
ROCE % |
10.85 | -11.25 | -11.92 | -8.18 | 4.16 | 13.34 | 7.84 | 9.20 | 11.96 | 7.99 | 2.19 | -82.24 | -92.34 |
Current Ratio |
2.0 | 1.8 | 1.9 | 1.7 | 3.0 | 0.9 | 3.4 | 3.2 | 16.4 | 15.4 | 7.8 | 3.3 | 8.0 |
DSO |
122.8 | 169.6 | 189.4 | 147.0 | 127.5 | 117.4 | 121.3 | 130.2 | 104.9 | 112.8 | 151.8 | - | - |
DIO |
217.7 | 246.0 | 258.5 | 228.2 | 278.4 | 202.4 | 174.2 | 195.9 | 385.0 | 239.2 | 128.7 | - | - |
DPO |
66.3 | 68.7 | 62.1 | 54.2 | 84.4 | 44.4 | 16.8 | 25.4 | 59.4 | 84.4 | 52.3 | - | 22999.9 |
Operating Cycle |
340.5 | 415.5 | 447.9 | 375.2 | 405.8 | 319.9 | 295.6 | 326.2 | 489.9 | 352.0 | 280.6 | - | - |
Cash Conversion Cycle |
274.2 | 346.8 | 385.8 | 321.0 | 321.4 | 275.5 | 278.8 | 300.8 | 430.5 | 267.5 | 228.3 | - | -22999.9 |
All numbers in USD currency
Quarterly Financial Ratios ANI Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.46 | 0.3 | 0.06 | - | -0.55 | -0.94 | -1.27 | - | -0.37 | -1.17 | 0.01 | -0.3 | 0.04 | -1.03 | -0.59 | -0.41 | 0.32 | 0.55 | 0.04 | 0.46 | 0.43 | 0.24 | 0.19 | -0.83 | 0.41 | 0.23 | 0.1 | -0.09 | 0.22 | 0.1 | 0.12 | 0.25 | 0.4 | 0.31 | 0.38 | 1.85 | 0.59 | -0.21 | 0.33 | - | 0.13 | -6.03 | - | -0.16 | -1295.1 | -1644.86 | -0.53 | -0.36 | -0.73 | -0.16 | -0.2 |
EBITDA per Share |
1.76 | 1.53 | 1.5 | - | 0.56 | 0.05 | -0.29 | - | 0.64 | -0.35 | 1.16 | - | 1.18 | -0.01 | 0.28 | - | 1.41 | 1.58 | 1.75 | - | 1.59 | 1.33 | 1.27 | - | 1.42 | 1.22 | 0.98 | - | 1.21 | 0.98 | 0.9 | - | 0.92 | 0.87 | 0.96 | - | 0.84 | -0.16 | 0.42 | - | 0.13 | -3.15 | - | - | - | 0.04 | -0.06 | - | -0.75 | -0.83 | -0.19 |
ROE % |
1.54 | -3.53 | -9.84 | -13.81 | -16.13 | -15.69 | -18.26 | -9.63 | -11.49 | -8.94 | -7.90 | -11.52 | -11.94 | -10.33 | -0.93 | 2.86 | 7.69 | 8.41 | 6.73 | 5.10 | 7.80 | 7.95 | 8.08 | 4.89 | 6.39 | 5.19 | 4.32 | 2.96 | 5.80 | 7.15 | 8.72 | 7.81 | 12.63 | 14.61 | 10.69 | 5.54 | 8.45 | 6.53 | -2.97 | -7.65 | 1.69 | -0.34 | 10.77 | -26.30 | -16.24 | -50.79 | -90.31 | -99.50 | -33.67 | -39.60 | -45.62 |
ROA % |
0.87 | -1.41 | -4.13 | -5.85 | -6.80 | -6.58 | -7.53 | -3.86 | -4.65 | -3.61 | -3.35 | -4.89 | -5.16 | -4.40 | -0.28 | 1.33 | 3.56 | 3.88 | 3.08 | 2.34 | 3.48 | 3.46 | 3.46 | 2.08 | 2.86 | 2.51 | 2.20 | 1.55 | 3.15 | 3.96 | 4.87 | 4.38 | 6.94 | 7.90 | 5.75 | 2.94 | 5.61 | 5.73 | -3.67 | -7.04 | -36.04 | -41.46 | -30.91 | -57.97 | -39.62 | -57.29 | -81.55 | -82.73 | -20.41 | -24.01 | -27.65 |
ROCE % |
8.75 | 2.97 | -4.20 | -11.71 | -13.58 | -13.83 | -17.80 | -8.47 | -8.30 | -5.01 | -2.68 | -8.18 | -10.55 | -8.54 | 1.61 | 7.68 | 15.68 | 17.36 | 16.68 | 17.92 | 16.35 | 16.56 | 16.88 | 16.21 | 12.75 | 12.08 | 11.14 | 11.84 | 14.99 | 15.60 | 17.79 | 20.43 | 24.22 | 24.80 | 17.79 | 14.31 | 8.58 | 4.70 | -2.76 | -6.25 | 2.26 | 0.76 | 8.61 | -16.98 | -1.16 | -36.10 | -69.28 | -88.16 | -34.45 | -34.55 | -43.48 |
Current Ratio |
2.0 | 2.0 | 1.8 | 1.8 | 1.8 | 1.8 | 1.9 | 1.9 | 1.7 | 1.7 | 1.8 | 1.7 | 1.7 | 1.7 | 1.7 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.7 | 1.7 | 1.7 | 1.7 | 2.1 | 2.1 | 2.1 | 2.1 | 2.3 | 2.3 | 2.3 | 2.3 | 2.2 | 2.1 | 2.1 | 2.1 | 12.6 | - | - | 4.8 | 1.3 | 1.3 | 0.8 | 2.3 | 2.5 | 2.5 | 2.5 | 2.5 |
DSO |
121.7 | 136.1 | 145.3 | - | 158.3 | 174.2 | 184.1 | - | 174.7 | 173.1 | 157.1 | 152.7 | 165.0 | 180.3 | 153.9 | 137.2 | 128.2 | 121.1 | 118.2 | 103.6 | 116.7 | 125.2 | 121.3 | 113.5 | 111.4 | 119.8 | 130.4 | 109.6 | 108.7 | 133.6 | 150.6 | 111.0 | 100.2 | 102.5 | 95.2 | 75.0 | 90.8 | 237.4 | 124.8 | - | 145.7 | 185.6 | 147.2 | 251.9 | 98.4 | 47.8 | - | - | - | - | - |
DIO |
200.1 | 224.4 | 252.9 | - | 261.4 | 227.1 | 219.5 | - | 241.7 | 260.8 | 275.6 | - | 275.8 | 268.1 | 228.0 | - | 292.9 | 281.1 | 274.7 | - | 236.8 | 222.7 | 172.5 | - | 163.3 | 163.0 | 177.9 | - | 143.3 | 202.6 | 529.4 | - | 374.7 | 388.9 | 346.7 | - | 224.1 | 324.1 | 192.0 | - | 118.5 | 147.9 | 119.9 | - | 110.4 | 60.5 | - | - | - | - | - |
DPO |
59.4 | 66.0 | 75.0 | - | 64.7 | 64.2 | 59.9 | - | 45.8 | 54.7 | 57.1 | - | 51.1 | 49.6 | 54.1 | - | 88.8 | 85.3 | 72.8 | - | 52.0 | 48.9 | 27.6 | - | 15.7 | 15.7 | 19.5 | - | 18.6 | 26.2 | 73.0 | - | 57.8 | 60.0 | 78.3 | - | 79.1 | 114.4 | 71.0 | - | 48.1 | 60.1 | 64.9 | - | 78.3 | 67.2 | - | - | - | - | - |
Operating Cycle |
321.8 | 360.5 | 398.2 | - | 419.7 | 401.4 | 403.6 | - | 416.4 | 434.0 | 432.7 | 152.7 | 440.8 | 448.4 | 381.9 | 137.2 | 421.2 | 402.2 | 392.9 | 103.6 | 353.5 | 347.9 | 293.8 | 113.5 | 274.7 | 282.8 | 308.4 | 109.6 | 252.0 | 336.2 | 680.0 | 111.0 | 474.9 | 491.5 | 441.9 | 75.0 | 314.9 | 561.5 | 316.8 | - | 264.2 | 333.5 | 267.1 | 251.9 | 208.9 | 108.3 | - | - | - | - | - |
Cash Conversion Cycle |
262.4 | 294.5 | 323.2 | - | 355.0 | 337.1 | 343.6 | - | 370.6 | 379.3 | 375.5 | 152.7 | 389.7 | 398.8 | 327.8 | 137.2 | 332.3 | 317.0 | 320.1 | 103.6 | 301.6 | 299.1 | 266.2 | 113.5 | 259.0 | 267.1 | 288.8 | 109.6 | 233.5 | 310.0 | 607.0 | 111.0 | 417.1 | 431.4 | 363.6 | 75.0 | 235.8 | 447.1 | 245.8 | - | 216.1 | 273.4 | 202.2 | 251.9 | 130.5 | 41.1 | - | - | - | - | - |
All numbers in USD currency